Literature DB >> 27448585

Immediate Dysfunction of Vaccine-Elicited CD8+ T Cells Primed in the Absence of CD4+ T Cells.

Nicholas M Provine1, Rafael A Larocca1, Malika Aid1, Pablo Penaloza-MacMaster1, Alexander Badamchi-Zadeh1, Erica N Borducchi1, Kathleen B Yates2, Peter Abbink1, Marinela Kirilova1, David Ng'ang'a1, Jonathan Bramson3, W Nicholas Haining4, Dan H Barouch5.   

Abstract

CD4(+) T cell help is critical for optimal CD8(+) T cell memory differentiation and maintenance in many experimental systems. In addition, many reports have identified reduced primary CD8(+) T cell responses in the absence of CD4(+) T cell help, which often coincides with reduced Ag or pathogen clearance. In this study, we demonstrate that absence of CD4(+) T cells at the time of adenovirus vector immunization of mice led to immediate impairments in early CD8(+) T cell functionality and differentiation. Unhelped CD8(+) T cells exhibited a reduced effector phenotype, decreased ex vivo cytotoxicity, and decreased capacity to produce cytokines. This dysfunctional state was imprinted within 3 d of immunization. Unhelped CD8(+) T cells expressed elevated levels of inhibitory receptors and exhibited transcriptomic exhaustion and anergy profiles by gene set enrichment analysis. Dysfunctional, impaired effector differentiation also occurred following immunization of CD4(+) T cell-deficient mice with a poxvirus vector. This study demonstrates that following priming with viral vectors, CD4(+) T cell help is required to promote both the expansion and acquisition of effector functions by CD8(+) T cells, which is accomplished by preventing immediate dysfunction.
Copyright © 2016 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27448585      PMCID: PMC4991249          DOI: 10.4049/jimmunol.1600591

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  85 in total

1.  CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes.

Authors:  Edith M Janssen; Edward E Lemmens; Tom Wolfe; Urs Christen; Matthias G von Herrath; Stephen P Schoenberger
Journal:  Nature       Date:  2003-02-09       Impact factor: 49.962

2.  IL-2 is not required for the initiation of CD8 T cell cycling but sustains expansion.

Authors:  Warren N D'Souza; Leo Lefrançois
Journal:  J Immunol       Date:  2003-12-01       Impact factor: 5.422

3.  Progressive loss of memory T cell potential and commitment to exhaustion during chronic viral infection.

Authors:  Jill M Angelosanto; Shawn D Blackburn; Alison Crawford; E John Wherry
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

4.  PD-1 dependent exhaustion of CD8+ T cells drives chronic malaria.

Authors:  Joshua M Horne-Debets; Rebecca Faleiro; Deshapriya S Karunarathne; Xue Q Liu; Katie E Lineburg; Chek Meng Poh; Gijsbert M Grotenbreg; Geoffrey R Hill; Kelli P A MacDonald; Michael F Good; Laurent Renia; Rafi Ahmed; Arlene H Sharpe; Michelle N Wykes
Journal:  Cell Rep       Date:  2013-12-05       Impact factor: 9.423

5.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

6.  Longitudinal requirement for CD4+ T cell help for adenovirus vector-elicited CD8+ T cell responses.

Authors:  Nicholas M Provine; Rafael A Larocca; Pablo Penaloza-MacMaster; Erica N Borducchi; Anna McNally; Lily R Parenteau; David R Kaufman; Dan H Barouch
Journal:  J Immunol       Date:  2014-04-28       Impact factor: 5.422

7.  Impact of epitope escape on PD-1 expression and CD8 T-cell exhaustion during chronic infection.

Authors:  Joseph N Blattman; E John Wherry; Sang-Jun Ha; Robbert G van der Most; Rafi Ahmed
Journal:  J Virol       Date:  2009-02-11       Impact factor: 5.103

8.  PD-L1 blockade synergizes with IL-2 therapy in reinvigorating exhausted T cells.

Authors:  Erin E West; Hyun-Tak Jin; Ata-Ur Rasheed; Pablo Penaloza-Macmaster; Sang-Jun Ha; Wendy G Tan; Ben Youngblood; Gordon J Freeman; Kendall A Smith; Rafi Ahmed
Journal:  J Clin Invest       Date:  2013-05-15       Impact factor: 14.808

9.  The VITAL assay: a versatile fluorometric technique for assessing CTL- and NKT-mediated cytotoxicity against multiple targets in vitro and in vivo.

Authors:  Ian F Hermans; Jonathan D Silk; Jianping Yang; Michael J Palmowski; Uzi Gileadi; Corinna McCarthy; Mariolina Salio; Franca Ronchese; Vincenzo Cerundolo
Journal:  J Immunol Methods       Date:  2004-02-01       Impact factor: 2.303

10.  Functional and genomic profiling of effector CD8 T cell subsets with distinct memory fates.

Authors:  Surojit Sarkar; Vandana Kalia; W Nicholas Haining; Bogumila T Konieczny; Shruti Subramaniam; Rafi Ahmed
Journal:  J Exp Med       Date:  2008-03-03       Impact factor: 14.307

View more
  20 in total

Review 1.  The opposing roles of CD4+ T cells in anti-tumour immunity.

Authors:  Tomasz Ahrends; Jannie Borst
Journal:  Immunology       Date:  2018-04-27       Impact factor: 7.397

2.  A transgenic mouse model for HLA-B*57:01-linked abacavir drug tolerance and reactivity.

Authors:  Marco Cardone; Karla Garcia; Mulualem E Tilahun; Lisa F Boyd; Sintayehu Gebreyohannes; Masahide Yano; Gregory Roderiquez; Adovi D Akue; Leslie Juengst; Elliot Mattson; Suryatheja Ananthula; Kannan Natarajan; Montserrat Puig; David H Margulies; Michael A Norcross
Journal:  J Clin Invest       Date:  2018-05-21       Impact factor: 14.808

3.  A Highly Attenuated Vesicular Stomatitis Virus-Based Vaccine Platform Controls Hepatitis B Virus Replication in Mouse Models of Hepatitis B.

Authors:  Safiehkhatoon Moshkani; Carolina Chiale; Sabine M Lang; John K Rose; Michael D Robek
Journal:  J Virol       Date:  2019-02-19       Impact factor: 5.103

4.  Adenovirus serotype 5 vaccine vectors trigger IL-27-dependent inhibitory CD4+ T cell responses that impair CD8+ T cell function.

Authors:  Rafael A Larocca; Nicholas M Provine; Malika Aid; M Justin Iampietro; Erica N Borducchi; Alexander Badamchi-Zadeh; Peter Abbink; David Ng'ang'a; Christine A Bricault; Eryn Blass; Pablo Penaloza-MacMaster; Kathryn E Stephenson; Dan H Barouch
Journal:  Sci Immunol       Date:  2016-11-04

5.  Lipid A analog CRX-527 conjugated to synthetic peptides enhances vaccination efficacy and tumor control.

Authors:  Elena Tondini; Niels R M Reintjens; Giulia Castello; Tsolere Arakelian; Marjolein Isendoorn; Marcel Camps; Jana Vree; Gijs A van der Marel; Dmitri V Filippov; Jeroen D C Codee; Ferry Ossendorp
Journal:  NPJ Vaccines       Date:  2022-06-23       Impact factor: 9.399

6.  An activation to memory differentiation trajectory of tumor-infiltrating lymphocytes informs metastatic melanoma outcomes.

Authors:  Abhinav Jaiswal; Akanksha Verma; Ruth Dannenfelser; Marit Melssen; Itay Tirosh; Benjamin Izar; Tae-Gyun Kim; Christopher J Nirschl; K Sanjana P Devi; Walter C Olson; Craig L Slingluff; Victor H Engelhard; Levi Garraway; Aviv Regev; Kira Minkis; Charles H Yoon; Olga Troyanskaya; Olivier Elemento; Mayte Suárez-Fariñas; Niroshana Anandasabapathy
Journal:  Cancer Cell       Date:  2022-05-09       Impact factor: 38.585

7.  Combined HDAC and BET Inhibition Enhances Melanoma Vaccine Immunogenicity and Efficacy.

Authors:  Alexander Badamchi-Zadeh; Kelly D Moynihan; Rafael A Larocca; Malika Aid; Nicholas M Provine; M Justin Iampietro; Ekaterina Kinnear; Pablo Penaloza-MacMaster; Peter Abbink; Eryn Blass; John S Tregoning; Darrell J Irvine; Dan H Barouch
Journal:  J Immunol       Date:  2018-09-24       Impact factor: 5.422

8.  MAIT cell activation augments adenovirus vector vaccine immunogenicity.

Authors:  Nicholas M Provine; Ali Amini; Lucy C Garner; Alexandra J Spencer; Christina Dold; Claire Hutchings; Laura Silva Reyes; Michael E B FitzPatrick; Senthil Chinnakannan; Blanche Oguti; Meriel Raymond; Marta Ulaszewska; Fulvia Troise; Hannah Sharpe; Sophie B Morgan; Timothy S C Hinks; Teresa Lambe; Stefania Capone; Antonella Folgori; Eleanor Barnes; Christine S Rollier; Andrew J Pollard; Paul Klenerman
Journal:  Science       Date:  2021-01-29       Impact factor: 47.728

9.  Induction of complex immune responses and strong protection against retrovirus challenge by adenovirus-based immunization depends on the order of vaccine delivery.

Authors:  Meike Kaulfuß; Ina Wensing; Sonja Windmann; Camilla Patrizia Hrycak; Wibke Bayer
Journal:  Retrovirology       Date:  2017-02-06       Impact factor: 4.602

Review 10.  Novel Concepts for HIV Vaccine Vector Design.

Authors:  Quazim A Alayo; Nicholas M Provine; Pablo Penaloza-MacMaster
Journal:  mSphere       Date:  2017-12-06       Impact factor: 4.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.